Dolutegravir plus lamivudine versus efavirenz plus tenofovir disoproxil fumarate and lamivudine in antiretroviral-naive adults with HIV-1 infection

Abstract Background Concerns regarding potential toxicity and drug-drug interactions during long-term treatment with three-drug active antiretroviral therapy (ART) regimens have been attracting increasing attention. We aimed to evaluate the efficacy and safety of dolutegravir (DTG) plus lamivudine (...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Lisi Deng, Chunna Li, Ping Chen, Xiaoqing Luo, Xinchun Zheng, Lanlan Zhou, Yi Zhou, Jinyu Xia, Zhongsi Hong
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2022-01-01
Ráidu:	BMC Infectious Diseases
Fáttát:	Dolutegravir Lamivudine Two-drug regimen Naive HIV
Liŋkkat:	https://doi.org/10.1186/s12879-021-06991-y
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!